2 unknown, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 2, Completed 1 |
Follow Hengli BTX-A: new trials by email Literature Review of Hengli BTX-A trials Research Report on Hengli BTX-A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB) Botulinum Toxin Type A for Injection, Placebo - Overactive Bladder | Phase 3 | Unknown | Lanzhou Institute of Biological Products Co., Ltd | 216 | 2016-03-01 | 2018-01-03 |
| A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine Botulinum Toxin Type A for Injection, Placebo - Chronic Migraine | Phase 3 | Unknown | Lanzhou Institute of Biological Products Co., Ltd | 288 | 2014-09-01 | 2018-01-03 |
| A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity Botulinum Toxin Type A for Injection, placebo - Cerebrovascular Accident | Phase 3 | Completed | Lanzhou Institute of Biological Products Co., Ltd | 180 | 2014-07-01 | 2016-09-26 |
Muscle Spasticity (1) · Stroke (1) · Urinary Bladder, Overactive (1)
Lanzhou Institute of Biological Products Co., Ltd (3)
Shengyuan Yu, archiater (1) · Xinhua Wan, archiater (1)